Delving into the Latest Updates on Xiangbei Welman Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Infectious Diseases

Urogenital Diseases

Small molecule drug

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	4
Nervous System Diseases	1
Immune System Diseases	1
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	5
Chemical drugs	1

Top 5 Target	Count

PBPs x β-lactamase	4
DAT(Dopamine transporter)	1

The primary objective of this study is to evaluate the safety, tolerability and pharmacokinetic (PK) profiles of ascending single orally administered doses of F-02-2-Na in adult subjects (to include the Mass Balance) & multiple orally administered doses of F-02-2-Na in adult subjects with Hyperuricemia.

Start Date15 Dec 2025

Sponsor / Collaborator

Guangdong Hengqin Xinchuangyi Biopharmaceutical Co., Ltd.

[+1]

CTR20253378

/ RecruitingNot Applicable

WYH-062在健康受试者中单中心、开放、随机、单剂量交叉空腹和餐后状态下的生物等效性试验

[Translation] A single-center, open-label, randomized, single-dose crossover bioequivalence study of WYH-062 in healthy subjects under fasting and fed conditions

1.主要目的比较空腹和餐后给药条件下，湘北威尔曼制药股份有限公司提供的盐酸伐地那非片（20mg）与Bayer AG持证的盐酸伐地那非片（20mg，商品名：Levitra®）在健康成年男性中吸收程度和速度的差异，评价其生物等效性。 2.次要目的评价空腹和餐后给药条件下，湘北威尔曼制药股份有限公司提供的盐酸伐地那非片（20mg）与Bayer AG持证的盐酸伐地那非片（20mg，商品名：Levitra®）在健康成年男性中的安全性。

[Translation]

1. Primary Objective To compare the extent and rate of absorption of vardenafil hydrochloride tablets (20 mg) supplied by Xiangbei Wellman Pharmaceutical Co., Ltd. and vardenafil hydrochloride tablets (20 mg, trade name: Levitra®) licensed by Bayer AG in healthy adult males under fasting and fed conditions, and to evaluate their bioequivalence. 2. Secondary Objective To evaluate the safety of vardenafil hydrochloride tablets (20 mg) supplied by Xiangbei Wellman Pharmaceutical Co., Ltd. and vardenafil hydrochloride tablets (20 mg, trade name: Levitra®) licensed by Bayer AG in healthy adult males under fasting and fed conditions.

Start Date11 Sep 2025

Sponsor / Collaborator

Xiangbei Welman Pharmaceutical Co., Ltd.

100 Clinical Results associated with Xiangbei Welman Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Xiangbei Welman Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Xiangbei Welman Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Xiangbei Welman Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

2

Phase 2

Phase 3

1

2

Approved

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Modafinil ( DAT )	Disorders of Excessive Somnolence More	Approved
Ceftriaxone Sodium/Sulbactam sodium ( PBPs x β-lactamase )	Bacterial Infections More	Approved
Ceftriaxone Sodium/Tazobactam Sodium ( PBPs x β-lactamase )	Bacterial lower respiratory infection More	Phase 3
Ceftazidime/Sulbactam sodium ( PBPs x β-lactamase )	Acute Bronchitis More	Phase 2
Ceftazidime/Tazobactam Sodium ( PBPs x β-lactamase )	Respiratory Tract Infections More	Phase 2